Dialysis of Sugammadex in Participants With Severe Renal Impairment (Study 19.4.333) (P05773)

NCT00656799 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuromuscular Blockade

Interventions

DRUG: sugammadex
DRUG: Rocuronium

Sponsor

Merck Sharp & Dohme LLC